Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck. [electronic resource]
Producer: 20070709Description: 244-50 p. digitalISSN:- 1699-048X
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Squamous Cell -- drug therapy
- Combined Modality Therapy
- Confidence Intervals
- Docetaxel
- Female
- Head and Neck Neoplasms -- drug therapy
- Humans
- Kaplan-Meier Estimate
- Karnofsky Performance Status
- Laryngeal Neoplasms -- drug therapy
- Larynx -- pathology
- Male
- Middle Aged
- Neoplasm Staging
- Neoplasms, Multiple Primary -- drug therapy
- Pharyngeal Neoplasms -- drug therapy
- Pharynx -- pathology
- Radiotherapy -- adverse effects
- Radiotherapy Dosage
- Taxoids -- administration & dosage
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.